Hillman Capital Management Inc. Decreases Stock Holdings in CVS Health Corporation $CVS

by · The Cerbat Gem

Hillman Capital Management Inc. trimmed its holdings in CVS Health Corporation (NYSE:CVS – Free Report) by 7.4% in the 2nd quarter, HoldingsChannel reports. The firm owned 92,997 shares of the pharmacy operator’s stock after selling 7,453 shares during the quarter. CVS Health makes up approximately 3.5% of Hillman Capital Management Inc.’s portfolio, making the stock its 7th largest holding. Hillman Capital Management Inc.’s holdings in CVS Health were worth $6,415,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently modified their holdings of CVS. Avion Wealth boosted its position in shares of CVS Health by 99.0% during the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 189 shares during the last quarter. Harbor Asset Planning Inc. bought a new position in shares of CVS Health during the 2nd quarter valued at about $30,000. Bell Investment Advisors Inc grew its position in shares of CVS Health by 119.8% during the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 248 shares in the last quarter. Roxbury Financial LLC increased its holdings in shares of CVS Health by 78.3% in the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 202 shares during the last quarter. Finally, ORG Partners LLC lifted its position in shares of CVS Health by 418.9% in the second quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after buying an additional 377 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on CVS. Zacks Research downgraded CVS Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 8th. The Goldman Sachs Group boosted their price target on shares of CVS Health from $93.00 to $95.00 and gave the stock a “buy” rating in a research report on Wednesday. UBS Group reiterated an “outperform” rating on shares of CVS Health in a research report on Wednesday. Cantor Fitzgerald restated an “overweight” rating on shares of CVS Health in a report on Wednesday. Finally, Wells Fargo & Company decreased their target price on shares of CVS Health from $103.00 to $102.00 and set an “overweight” rating on the stock in a research report on Thursday, November 13th. Two analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $93.71.

Check Out Our Latest Analysis on CVS

CVS Health Price Performance

CVS stock opened at $79.45 on Friday. The stock has a market cap of $100.85 billion, a PE ratio of 209.08, a P/E/G ratio of 0.80 and a beta of 0.48. CVS Health Corporation has a 12 month low of $43.56 and a 12 month high of $85.15. The company has a 50-day moving average price of $78.97 and a 200 day moving average price of $71.83. The company has a current ratio of 0.83, a quick ratio of 0.63 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVS – Get Free Report) last posted its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The company had revenue of $102.87 billion for the quarter, compared to analyst estimates of $98.85 billion. During the same period in the prior year, the company posted $1.09 EPS. The firm’s revenue for the quarter was up 7.8% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Equities research analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd were given a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.3%. The ex-dividend date of this dividend was Thursday, October 23rd. CVS Health’s dividend payout ratio is 700.00%.

About CVS Health

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

See Also

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS – Free Report).